未登录

A

Anna Mantovani

University of Verona and Hospital Trust of Verona

H指数:9

被引数:321

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Response to: “The Role of Platelets in MASLD: From Mechanisms to Clinical Implications”

回应：“血小板在MASLD中的作用：从机制到临床意义”

Liver International

IF5.2

2025-09-010

PRE

Platelet Functional Profile Is Altered in Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍相关脂肪性肝病中血小板功能表型发生改变

Liver International

IF5.2

2025-07-280

OAAI

Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients

DIGESTIVE AND LIVER DISEASE

IF3.8

2024-03-016

OAAI

Author's Reply: Bacterial infections predispose to the development of portal vein thrombosis in patients with decompensated cirrhosis

DIGESTIVE AND LIVER DISEASE

IF3.8

2024-02-010

PRE

Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application

代谢相关脂肪肝和肝纤维化评分作为新型冠状病毒肺炎结果预测因子: 机器学习应用

INTERNAL AND EMERGENCY MEDICINE

IF3.8

2023-06-032

OAAI

Bacterascites confers poor patient prognosis beyond MELD prediction

LIVER TRANSPLANTATION

IF3.9

2023-01-255

OA

Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

IF3.7

2022-12-016

OAAI

Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease

LIVER INTERNATIONAL

IF5.2

2022-06-159

OA

The impact of a local antibiotic stewardship program: Low rate of spontaneous bacterial peritonitis and bacteriascites sustained by multidrug-resistant organisms

DIGESTIVE AND LIVER DISEASE

IF3.8

2021-03-010

PREAI

Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19

LIVER INTERNATIONAL

IF5.2

2020-07-0598

OAAI

A multidisciplinary approach to non-alcoholic fatty liver disease (NAFLD) improves cardiovascular risk factors: the experience of a tertiary liver center in UK

DIGESTIVE AND LIVER DISEASE

IF3.8

2020-02-010

PREAI

Spleen stiffness measured with ElastPQ point shear wave elastography has a good performance in predicting clinically significant portal hypertension in patients with primary sclerosing cholangitis

JOURNAL OF HEPATOLOGY

IF33

2019-04-010

PREAI

Cardiovascular risk factors and fibrosis severity in NAFLD: is there a link?

JOURNAL OF HEPATOLOGY

IF33

2019-04-010

PREAI

Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes

DIGESTIVE AND LIVER DISEASE

IF3.8

2019-02-010

PREAI

Effects of DAAs (direct-acting antivirals) on cardiac function and structure in hepatitis c (HCV) patients with low-mild liver fibrosis

DIGESTIVE AND LIVER DISEASE

IF3.8

2019-02-010

PREAI

Non-alcoholic fatty liver disease is omega-6 fatty acids diet dipendent in a group of obese children

JOURNAL OF HEPATOLOGY

IF33

2018-04-010

PREAI

The wrong or right effects of HCV on cardiac function in patients with low-mild liver fibrosis: A case-control study

JOURNAL OF HEPATOLOGY

IF33

2018-04-010

PREAI

Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children

EUROPEAN JOURNAL OF NUTRITION

IF4.3

2018-03-2820

PREAI

OMEGA-6 FATTY ACIDS IN ERYTHROCYTE MEMBRANE ARE INVERSELY ASSOCIATED WITH SEVERAL FEATURES OF THE METABOLIC SYNDROME IN A GROUP OF OBESE CHILDREN

JOURNAL OF HYPERTENSION

IF4.1

2017-09-010

PREAI